Sweden · Delayed Price · Currency is SEK Fluicell AB Company Description
Fluicell AB (publ) operates as a life science company, provides platforms and research solutions for bioprinting and single-cell biology.
The company offers BIOPEN, a microfluidic platform for high-precision single-cell solution delivery that enables to control the cell microenvironment without moving or disturbing the cells; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds; and Dynaflow Resolve system, an ion channel screening platform, which allows to record various ion channel current in patch-clamp recording configuration.
It also provides Biopixlar, a 3D single-cell bioprinting platform that enables high cell viability and cell-to-cell communication; and Biopixlar AER, an easy-to-use 3D bioprinting platform that fits into your fume hood or biosafety cabinet.
The company also offers accessory and consumable products for bioprinting and single-cell biology. The company was incorporated in 2012 and is based in Mölndal, Sweden.
| Country | Sweden |
| Founded | 2012 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 12 |
| CEO | Carolina Trjulja |
Contact Details
Address: Flöjelbergsgatan 8C Mölndal, 431 37 Sweden | |
| Phone | 46 7 62 08 33 54 |
| Website | fluicell.com |
Stock Details
| Ticker Symbol | FLUI |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0010831321 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Carolina Trjulja | Chief Executive Officer |
| Gavin D. M. Jeffries | Co-Founder, Chief Technology Officer and Director |
| Joakim Wahlberg | Chief Financial Officer |
| Jonas Hannestad | Chief Marketing and Communications Officer |